Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery

被引:15
|
作者
Rader, Florian [1 ]
Pujara, Akshat C. [2 ]
Pattakos, Gregory [3 ]
Rajeswaran, Jeevanantham [4 ]
Li, Liang [4 ]
Castel, Laurie [5 ]
Chung, Mina K. [6 ]
Gillinov, A. Marc [3 ]
Costantini, Otto [7 ]
Van Wagoner, David R. [5 ,6 ]
Blackstone, Eugene H. [3 ,4 ]
机构
[1] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA
[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[3] Cleveland Clin, Inst Heart & Vasc, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44106 USA
[4] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA
[5] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44106 USA
[6] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44106 USA
[7] Case Western Reserve Univ, Heart & Vasc Ctr, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Atrial fibrillation; Postoperative; Biomarker; Ischemia; CABG; Valve surgery; ON-PUMP; CORONARY; ARRHYTHMIAS; RANOLAZINE; REVASCULARIZATION; PREDICTORS; AMIODARONE; PREVENTION; INFARCTION; BLOCKADE;
D O I
10.1016/j.hrthm.2012.10.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Postoperative atrial fibrillation (POAF) is common and associated with poor outcomes. Perioperative ischemia can alter arrhythmic substrate. OBJECTIVE To demonstrate an association between perioperative measurements of heart-type fatty acid binding protein (HT-FABP), a sensitive marker of ischemic myocardial injury. METHODS Blood samples from 63 inpatients undergoing coronary artery bypass surgery, valve surgery, or both were obtained before and up to 4 days after surgery. Continuous telemetry monitoring was used to detect POAF. Fifty-nine patients had at least 3 HT-FABP measurements. The relationship of enzyme-linked immunosorbent assay-measured HT-FABP with POAF was assessed by using joint logistic regression adjusted for age and surgery type. RESULTS Thirty-five patients (55%) developed POAF; these were, on average, order (69.3 +/- 10 years vs 60 +/- 11 years; P = .0019), with a higher prevalence of heart failure (43% vs 17%; P = .034), chronic obstructive lung disease (26% vs 4%; P = .017), preoperative calcium channel blocker use (29% vs 7%; P = .031), and more likely to undergo combined surgery (21% vs 11%, P = .049). The joint age- and coronary artery bypass surgery-adjusted model revealed that postoperative but not preoperative HT-FABP levels predicted POAF (coefficient 1.9 +/- 0.87; P = .03). longer bypass time, prior infarction, and worse renal function were all associated with higher postoperative HT-FABP. CONCLUSIONS A greater rise of HT-FABP is associated with atrial fibrillation after cardiac surgery, suggesting that ischemic myocardial damage is a contributing underlying mechanism. Interventions that decrease perioperative ischemic injury may also decrease the occurrence of POAF.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 50 条
  • [41] AN AUDIT OF HEART-TYPE FATTY ACID-BINDING PROTEIN (H-FABP) IN ACUTE CARDIAC ADMISSIONS
    Connolly, M.
    Kinnin, M.
    McEneaney, D.
    HEART, 2015, 101 : A28 - A29
  • [42] Heart-Type Fatty Acid Binding Protein Level as a Tool in Identification of Early Cardiac Effects of Diabetic Ketoacidosis
    Yilmaz, Fatma Hilal
    Yuca, Sevil Ari
    Vatansev, Husamettin
    Cimbek, Emine Ayca
    Sen, Yasar
    Yilmaz, Isa
    Akyurek, Fikret
    Arslan, Derya
    Cimen, Derya
    Yorulmaz, Alaaddin
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2017, 9 (02) : 118 - 123
  • [43] Elevated Levels of Heart-Type Fatty Acid-Binding Protein Predict Adverse Outcomes in Hypertensive Patients
    Setsuta, Koichi
    Kitahara, Yasuyuki
    Arao, Masato
    Ohbayashi, Taminori
    Seino, Yoshihiko
    Mizuno, Kyoichi
    CIRCULATION, 2009, 120 (18) : S1163 - S1164
  • [44] Heart-type fatty acid binding protein testing and risk assessment of heart failure patients
    Gruson, D. Damien
    Adamantidou, C.
    Adamantidou, C.
    Ahn, S.
    Ahn, S.
    Rousseau, M. F.
    Rousseau, M. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 64 - 64
  • [45] Human heart-type fatty acid-binding protein as an early diagnostic marker of doxorubicin cardiac toxicity
    ElGhandour, Ashraf H.
    El Sorady, Manal
    Azab, Sahar
    ElRahman, Mohammed
    HEMATOLOGY REPORTS, 2009, 1 (01) : 29 - 32
  • [46] Heart-Type Fatty Acid Binding Protein Is an Independent Predictor of Death and Ventricular Dysfunction After Coronary Artery Bypass Graft Surgery
    Muehlschlegel, Jochen D.
    Perry, Tjoervi E.
    Liu, Kuang-Yu
    Fox, Amanda A.
    Collard, Charles D.
    Shernan, Stanton K.
    Body, Simon C.
    ANESTHESIA AND ANALGESIA, 2010, 111 (05): : 1101 - 1109
  • [47] IMMUNOTURBIDIMETRIC ASSAY KIT FOR THE RAPID MEASUREMENT OF HEART-TYPE FATTY ACID BINDING PROTEIN
    Lowry, P.
    Szabo, M.
    Henry, C.
    McConnell, R., I
    Fitzgerald, S. P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S303 - S303
  • [48] Usefulness of heart-type fatty acid-binding protein in patients with severe sepsis
    Zhang, Zhao-cai
    Dai, Hai-wen
    Yu, Yi-hua
    Yang, Ji-dong
    Hu, Cai-bao
    JOURNAL OF CRITICAL CARE, 2012, 27 (04)
  • [49] Heart-type fatty acid binding protein and the diagnosis of acute coronary syndrome in the ED
    Freund, Yonathan
    Chenevier-Gobeaux, Camille
    Leumani, Francois
    Claessens, Yann-Erick
    Allo, Jean-Christophe
    Doumenc, Benoit
    Cosson, Claudine
    Bonnet, Pascale
    Riou, Bruno
    Ray, Patrick
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2012, 30 (08): : 1378 - 1384
  • [50] Overexpression of heart-type fatty acid binding protein enhances fatty acid-induced podocyte injury
    Gao, Qing
    Sarkar, Alhossain
    Chen, Yizhi
    Xu, Bo
    Zhu, Xiaojuan
    Yuan, Yang
    Guan, Tianjun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 2054 - 2061